<DOC>
	<DOCNO>NCT01115569</DOCNO>
	<brief_summary>This Phase 3 , multi-center study evaluate long-term safety tolerability hydrocodone bitartrate control release capsule ( HC-CR ) daily dose 40 mg subject moderate severe chronic pain . Long-term maintenance HC-CR efficacy evaluate .</brief_summary>
	<brief_title>Long-Term Study Hydrocodone Bitartrate Controlled-release Capsules Subjects With Chronic Pain</brief_title>
	<detailed_description>Subjects go screen , open-label conversion titration phase 6 week follow open-label treatment phase 48 week 2 week follow-up period .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Hydrocodone</mesh_term>
	<criteria>Subjects must diagnose moderate severe chronic pain condition treat aroundtheclock opioids least past 3 month Investigator 's opinion qualify aroundtheclock opioid therapy treatment pain Subjects must take opioids least 5 days/week past month average daily dose least 30 mg hydrocodone Subjects must able complete study procedure attend clinic visit 6 12 month Females subject childbearing potential must negative urine pregnancy test Screen Visit , must consent use medicallyacceptable method contraception throughout entire study period . Subjects must adequate medical evaluation treatment underlie painful condition appropriate primary medical/surgical therapy underlie condition Subjects must voluntarily provide write informed consent Any clinically significant condition would , opinion investigator , preclude study participation interfere assessment pain increase risk opioidrelated adverse event ( AEs ) A medical condition , opinion Investigator , would compromise subject 's ability swallow , absorb , metabolize , excrete study drug A surgical procedure pain within last 3 month Uncontrolled blood pressure , i.e. , sit systolic blood pressure &gt; 180 mm Hg &lt; 90 mm Hg , and/or sit diastolic blood pressure &gt; 120 mm Hg &lt; 50 mm Hg Screening A body mass index ( BMI ) &gt; 45 kg/m2 A hospital anxiety depression scale ( HADS ) score &gt; 12 either depression anxiety subscales establish history psychiatric disorder poorly control A clinically significant abnormality clinical chemistry , hematology urinalysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>chronic pain</keyword>
</DOC>